Algae Dynamics Corp. announced a joint venture with ARA - Avanti Rx Analytics Inc. in a newly-formed subsidiary entity called ADC Biomedical Corp, the equity of which will be owned 4% and 96% by ARA and ADC, respectively. Previously, the company had announced a memorandum of understanding with ARA with respect to strategic collaboration between the two companies. This announcement is an extension of that previously-announced collaboration. It is the intention of the joint venture for BIO to be the preferred purchaser from ARA of all BIO's and ADC's products containing algae, hemp oil, and cannabis extracted oils, and/or their compounds.